MediCrops Holding AG is a pioneering Swiss company specializing in the cultivation, processing, and distribution of high-quality medicinal cannabis. Focused on meeting the growing demand for cannabis-based treatments, MediCrops combines advanced agricultural techniques with strict quality controls to produce pharmaceutical-grade cannabis products. The company is dedicated to providing safe, effective, and sustainable solutions for the medical community, addressing various health conditions with a commitment to innovation and regulatory compliance.
Founded: 2019
Ivan Mestrangelo Co-Founder, Co-Chief Executive Officer, and Chairman |
Eva Vaoutsi Co-Chief Executive Officer |
Luitpold Wüsthof Chief Financial Officer |
Toby Shillito Chief Business Development Officer |